ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,740.42
      -0.09%
      US Tech 100
      19,449.20
      -0.66%
      Dow Jones
      42,350.29
      0.42%
      Brent Oil
      71.695
      1.05%
      Bitcoin
      65,816.74
      0.97%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Cerevel Therapeutics Holdings Inc (CERE)

      7. Cerevel Therapeutics Holdings Inc (CERE) News

      CERE

      Cerevel Therapeutics (CERE)

      Cerevel Therapeutics Holdings Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:CERE
      DateTimeSourceHeadlineSymbolCompany
      08/12/20247:30AMEdgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:CERECerevel Therapeutics Holdings Inc
      08/06/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CERECerevel Therapeutics Holdings Inc
      08/06/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CERECerevel Therapeutics Holdings Inc
      08/06/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CERECerevel Therapeutics Holdings Inc
      08/05/20244:38PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CERECerevel Therapeutics Holdings Inc
      08/05/20244:34PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CERECerevel Therapeutics Holdings Inc
      08/05/20244:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CERECerevel Therapeutics Holdings Inc
      08/05/20244:30PMEdgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:CERECerevel Therapeutics Holdings Inc
      08/05/20244:29PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CERECerevel Therapeutics Holdings Inc
      08/05/20244:26PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CERECerevel Therapeutics Holdings Inc
      08/05/20244:24PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CERECerevel Therapeutics Holdings Inc
      08/01/20249:33AMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:CERECerevel Therapeutics Holdings Inc
      08/01/20249:32AMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:CERECerevel Therapeutics Holdings Inc
      08/01/20249:27AMEdgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:CERECerevel Therapeutics Holdings Inc
      08/01/20249:26AMEdgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:CERECerevel Therapeutics Holdings Inc
      08/01/20249:25AMEdgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:CERECerevel Therapeutics Holdings Inc
      08/01/20249:24AMEdgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:CERECerevel Therapeutics Holdings Inc
      08/01/20248:36AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CERECerevel Therapeutics Holdings Inc
      08/01/20248:23AMPR Newswire (US)AbbVie Completes Acquisition of Cerevel TherapeuticsNASDAQ:CERECerevel Therapeutics Holdings Inc
      05/08/20244:17PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CERECerevel Therapeutics Holdings Inc
      04/18/20246:30AMGlobeNewswire Inc.Cerevel Therapeutics Announces Positive Topline Results for Tavapadon in Phase 3 Adjunctive Trial for People Living with Parkinson’s DiseaseNASDAQ:CERECerevel Therapeutics Holdings Inc
      02/27/20244:02PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:CERECerevel Therapeutics Holdings Inc
      02/16/20244:46PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CERECerevel Therapeutics Holdings Inc
      02/09/20249:00AMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:CERECerevel Therapeutics Holdings Inc
      02/08/20247:19PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CERECerevel Therapeutics Holdings Inc
      01/24/20248:30AMPR Newswire (US)Kuehn Law Encourages MDC, WAVD, NS and CERE Investors to Contact Law FirmNASDAQ:CERECerevel Therapeutics Holdings Inc
      01/23/20245:51PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CERECerevel Therapeutics Holdings Inc
      01/23/20245:50PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CERECerevel Therapeutics Holdings Inc
      01/23/20245:46PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CERECerevel Therapeutics Holdings Inc
      01/23/20245:37PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CERECerevel Therapeutics Holdings Inc
       Showing the most relevant articles for your search:NASDAQ:CERE